Kathleen Ensor

Evaluation of the safety, reactogenicity and immunogenicity of FluBlok® trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy adults 50–64 years of age☆

Roger Baxter, P. Patriarca, Kathleen Ensor et al. · Vaccine · 2011 · 107 citations

Vaccinology, Vaccine Safety, Vaccination +9

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal ACWY Tetanus Toxoid Conjugate Vaccine in Healthy Adolescents and Young Adults 10 to 25 Years of Age

Roger Baxter, Yaela Baine, Kathleen Ensor et al. · The Pediatric Infectious Disease Journal · 2010 · 65 citations

Vaccination with measles, mumps and rubella vaccine and varicella vaccine: safety, tolerability, immunogenicity, persistence of antibody and duration of protection against varicella in healthy children

Henry R. Shinefield, Steven Black, BRENDA O. STAEHLE et al. · The Pediatric Infectious Disease Journal · 2002 · 63 citations

Safety, tolerability and immunogenicity of concomitant injections in separate locations of M-M-R®II, VARIVAX® and TETRAMUNE® in healthy children vs. concomitant injections of M-M-R®II and TETRAMUNE® followed six weeks later by VARIVAX®

Henry R. Shinefield, Steven Black, BRENDA O. STAEHLE et al. · The Pediatric Infectious Disease Journal · 1998 · 23 citations

Diphtheria-Tetanus-Acellular Pertussis and Inactivated Poliovirus Vaccines Given Separately or Combined for Booster Dosing at 4–6 Years of Age

Steven Black, Leonard R. Friedland, Kathleen Ensor et al. · The Pediatric Infectious Disease Journal · 2008 · 20 citations